Poolbeg Pharma wants to look into the potential of microencapsulation and nanoencapsulation oral delivery technologies for treating chronic conditions.
Read more: Licencing deal paves way for new treatment methods for metabolic diseases
Poolbeg Pharma wants to look into the potential of microencapsulation and nanoencapsulation oral delivery technologies for treating chronic conditions.
Read more: Licencing deal paves way for new treatment methods for metabolic diseases